View in EDS HTML Full Text PDF Full Text

Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.

Saved in:
Bibliographic Details
Title: Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.
Authors: Colton H; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Barratt N; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham, UK., Hornsby H; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Angyal A; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Grouneva I; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Lindsey BB; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Kearns P; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Barnes E; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Goodyear CS; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Richter A; Clinical Immunology Service, University of Birmingham, Birmingham, UK., Thomas D; The Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, UK., Cook G; National Institute for Health Research, Leeds MIC, University of Leeds, Leeds, UK., McInnes IB; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Willicombe M; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK., Siebert S; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Orchard K; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Selby R; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Bowden S; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Collini PJ; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Pope A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Kirkham A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Kronsteiner B; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Dunachie SJ; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Miller P; British Society of Blood and Marrow Transplantation and Cellular Therapy, Guy's Hospital, London, UK., Clay J; Department of Haematology, St James's University Hospital, Leeds, UK., Hurst E; Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Malladi R; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Kesavan M; Department of Oncology, Cancer and Haematology Centre, Churchill Hospital, Oxford, UK., Kinsella F; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Sanderson R; King's College Hospital NHS Foundation Trust, London, UK., Yong KL; Department of Haematology, Cancer Institute, University College London, London, UK., Rea D; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Parry H; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Lim SH; Centre for Cancer Immunology, University of Southampton, Southampton, UK., Snowden JA; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., de Silva TI; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
Corporate Authors: PITCH Consortium, OCTAVE Collaborative Group, OCTAVE‐DUO Investigators, PROSECO Investigators
Source: British journal of haematology [Br J Haematol] 2024 Dec; Vol. 205 (6), pp. 2206-2218. Date of Electronic Publication: 2024 Nov 17.
Publication Type: Journal Article; Multicenter Study; Comparative Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39551718
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Colton+H%22">Colton H</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Barratt+N%22">Barratt N</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Temperton+N%22">Temperton N</searchLink>; Viral Pseudotype Unit, Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham, UK.<br /><searchLink fieldCode="AU" term="%22Hornsby+H%22">Hornsby H</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Angyal+A%22">Angyal A</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Grouneva+I%22">Grouneva I</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Lindsey+BB%22">Lindsey BB</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Kearns+P%22">Kearns P</searchLink>; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Barnes+E%22">Barnes E</searchLink>; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Goodyear+CS%22">Goodyear CS</searchLink>; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Richter+A%22">Richter A</searchLink>; Clinical Immunology Service, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Thomas+D%22">Thomas D</searchLink>; The Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Cook+G%22">Cook G</searchLink>; National Institute for Health Research, Leeds MIC, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22McInnes+IB%22">McInnes IB</searchLink>; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Willicombe+M%22">Willicombe M</searchLink>; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Siebert+S%22">Siebert S</searchLink>; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Orchard+K%22">Orchard K</searchLink>; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Selby+R%22">Selby R</searchLink>; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Bowden+S%22">Bowden S</searchLink>; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Collini+PJ%22">Collini PJ</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Pope+A%22">Pope A</searchLink>; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Kirkham+A%22">Kirkham A</searchLink>; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Kronsteiner+B%22">Kronsteiner B</searchLink>; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Dunachie+SJ%22">Dunachie SJ</searchLink>; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Miller+P%22">Miller P</searchLink>; British Society of Blood and Marrow Transplantation and Cellular Therapy, Guy's Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Clay+J%22">Clay J</searchLink>; Department of Haematology, St James's University Hospital, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Hurst+E%22">Hurst E</searchLink>; Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK.<br /><searchLink fieldCode="AU" term="%22Malladi+R%22">Malladi R</searchLink>; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kesavan+M%22">Kesavan M</searchLink>; Department of Oncology, Cancer and Haematology Centre, Churchill Hospital, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Kinsella+F%22">Kinsella F</searchLink>; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Sanderson+R%22">Sanderson R</searchLink>; King's College Hospital NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Yong+KL%22">Yong KL</searchLink>; Department of Haematology, Cancer Institute, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Rea+D%22">Rea D</searchLink>; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Parry+H%22">Parry H</searchLink>; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Lim+SH%22">Lim SH</searchLink>; Centre for Cancer Immunology, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Snowden+JA%22">Snowden JA</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22de+Silva+TI%22">de Silva TI</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PITCH+Consortium%2C+OCTAVE+Collaborative+Group%2C+OCTAVE‐DUO+Investigators%2C+PROSECO+Investigators%22">PITCH Consortium, OCTAVE Collaborative Group, OCTAVE‐DUO Investigators, PROSECO Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2024 Dec; Vol. 205 (6), pp. 2206-2218. <i>Date of Electronic Publication: </i>2024 Nov 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39551718
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.19874
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2206
    Titles:
      – TitleFull: Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Colton H
      – PersonEntity:
          Name:
            NameFull: Barratt N
      – PersonEntity:
          Name:
            NameFull: Temperton N
      – PersonEntity:
          Name:
            NameFull: Hornsby H
      – PersonEntity:
          Name:
            NameFull: Angyal A
      – PersonEntity:
          Name:
            NameFull: Grouneva I
      – PersonEntity:
          Name:
            NameFull: Lindsey BB
      – PersonEntity:
          Name:
            NameFull: Kearns P
      – PersonEntity:
          Name:
            NameFull: Barnes E
      – PersonEntity:
          Name:
            NameFull: Goodyear CS
      – PersonEntity:
          Name:
            NameFull: Richter A
      – PersonEntity:
          Name:
            NameFull: Thomas D
      – PersonEntity:
          Name:
            NameFull: Cook G
      – PersonEntity:
          Name:
            NameFull: McInnes IB
      – PersonEntity:
          Name:
            NameFull: Willicombe M
      – PersonEntity:
          Name:
            NameFull: Siebert S
      – PersonEntity:
          Name:
            NameFull: Orchard K
      – PersonEntity:
          Name:
            NameFull: Selby R
      – PersonEntity:
          Name:
            NameFull: Bowden S
      – PersonEntity:
          Name:
            NameFull: Collini PJ
      – PersonEntity:
          Name:
            NameFull: Pope A
      – PersonEntity:
          Name:
            NameFull: Kirkham A
      – PersonEntity:
          Name:
            NameFull: Kronsteiner B
      – PersonEntity:
          Name:
            NameFull: Dunachie SJ
      – PersonEntity:
          Name:
            NameFull: Miller P
      – PersonEntity:
          Name:
            NameFull: Clay J
      – PersonEntity:
          Name:
            NameFull: Hurst E
      – PersonEntity:
          Name:
            NameFull: Malladi R
      – PersonEntity:
          Name:
            NameFull: Kesavan M
      – PersonEntity:
          Name:
            NameFull: Kinsella F
      – PersonEntity:
          Name:
            NameFull: Sanderson R
      – PersonEntity:
          Name:
            NameFull: Yong KL
      – PersonEntity:
          Name:
            NameFull: Rea D
      – PersonEntity:
          Name:
            NameFull: Parry H
      – PersonEntity:
          Name:
            NameFull: Lim SH
      – PersonEntity:
          Name:
            NameFull: Snowden JA
      – PersonEntity:
          Name:
            NameFull: de Silva TI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 205
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1